CELU
Celularity Inc.$1.05+0.04 (+3.96%)Prev Close$1.01·MCap$23.8M·P/E—·Vol105.0K·Yield—
▲
Buys (12M)
0
$0.00
▼
Sells (12M)
0
$0.00
◆
Net Activity
Net Buyer
$0.00
●
Active Insiders
0
last 12 mo
CELU Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Apr 13, 2025 | Beers David C | Chief Financial Officer | Sell | 360 | $1.64 | $590.40 | 0 |
| Apr 13, 2025 | Brigido Stephen | Pres., Functional Regeneration | Sell | 268 | $1.64 | $439.52 | 0 |
| Apr 13, 2025 | Haines John R | Senior Exec Vice President | Sell | 577 | $1.64 | $946.28 | 0 |
| Apr 13, 2025 | Hariri Robert J | Chief Executive Officer | Sell | 1,154 | $1.64 | $1.9K | 0 |
| Feb 17, 2025 | Beers David C | Chief Financial Officer | Sell | 4,396 | $2.14 | $9.4K | 0 |
| Feb 17, 2025 | Brigido Stephen | Pres., Functional Regeneration | Sell | 3,272 | $2.14 | $7.0K | 0 |
| Feb 17, 2025 | Haines John R | Senior Exec Vice President | Sell | 7,035 | $2.14 | $15.1K | 0 |
| Jan 24, 2025 | Lim Kok Thay | 10% Owner | Sell | 1,188,255 | $2.07 | $2.46M4.9% OS | 0 |
| Apr 13, 2024 | Beers David C | Chief Financial Officer | Sell | 360 | $4.11 | $1.5K | 0 |
| Apr 13, 2024 | Brigido Stephen | Pres, Functional Regeneration | Sell | 268 | $4.11 | $1.1K | 0 |
| Apr 13, 2024 | Fletcher Kyle | See Remarks | Sell | 20 | $4.11 | $82.20 | 0 |
| Apr 13, 2024 | Haines John R | See Remarks | Sell | 576 | $4.11 | $2.4K | 0 |
| Apr 13, 2024 | Hariri Robert J | Chief Executive Officer | Sell | 1,154 | $4.11 | $4.7K | 0 |
| Mar 15, 2024 | Fletcher Kyle | See Remarks | Sell | 617 | $5.68 | $3.5K | 0 |
| Feb 16, 2024 | Beers David C | Chief Financial Officer | Sell | 43,968 | $0.43 | $19.1K | 0 |
| Feb 16, 2024 | Brigido Stephen | Pres, Functional Regeneration | Sell | 32,720 | $0.43 | $14.2K | 0 |
| Feb 16, 2024 | Fletcher Kyle | See Remarks | Sell | 39,571 | $0.43 | $17.2K | 0 |
| Feb 16, 2024 | Haines John R | See Remarks | Sell | 70,350 | $0.43 | $30.5K | 0 |
| Feb 16, 2024 | Kilcoyne Adrian | Chief Medical Officer | Sell | 52,762 | $0.43 | $22.9K | 0 |
| Jan 12, 2024 | Lim Kok Thay | 10% Owner | Buy | 21,410,983 | $0.25 | $5.33M89.0% OS | 0 |
| Sep 29, 2023 | Hariri Robert J | Chief Executive Officer | Buy | 18,422,124 | $0.16 | $2.98M76.6% OS | 0 |
| Apr 13, 2023 | Beers David C | Chief Financial Officer | Sell | 3,606 | $0.71 | $2.6K | 0 |
| Apr 13, 2023 | Brigido Stephen | Pres, Functional Regeneration | Sell | 2,683 | $0.71 | $1.9K | 0 |
| Apr 13, 2023 | Fletcher Kyle | See Remarks | Sell | 201 | $0.71 | $143.53 | 0 |
| Apr 13, 2023 | Glover Bradley | See Remarks | Sell | 2,884 | $0.71 | $2.1K | 0 |
| Apr 13, 2023 | Haines John R | See Remarks | Sell | 5,770 | $0.71 | $4.1K | 0 |
| Apr 13, 2023 | Hariri Robert J | Chief Executive Officer | Sell | 11,540 | $0.71 | $8.2K | 0 |
| Mar 15, 2023 | Fletcher Kyle | See Remarks | Sell | 2,170 | $0.63 | $1.4K | 0 |
| Nov 30, 2022 | Hariri Robert J | Chief Executive Officer | Buy | 10,000 | $1.72 | $17.2K | 0 |
| Nov 29, 2022 | Hariri Robert J | Chief Executive Officer | Buy | 40,000 | $1.71 | $68.4K | 0 |
| Nov 28, 2022 | Hariri Robert J | Chief Executive Officer | Buy | 40,000 | $1.74 | $69.6K | 0 |
| Nov 16, 2022 | Fletcher Kyle | General Counsel | Sell | 1,262 | $1.89 | $2.4K | 0 |
| Nov 16, 2021 | Glover Bradley | See Remarks | Sell | 3,734 | $1.89 | $7.1K | 0 |
| Nov 16, 2021 | Jones Anne | Chief Business Officer | Sell | 3,734 | $1.89 | $7.1K | 0 |
CELU Insider Buying Activity
The following table shows recent insider purchases of Celularity Inc. (CELU) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jan 12, 2024 | Lim Kok Thay | 10% Owner | Buy | 21,410,983 | $0.25 | $5.33M89.0% OS | 0 |
| Sep 29, 2023 | Hariri Robert J | Chief Executive Officer | Buy | 18,422,124 | $0.16 | $2.98M76.6% OS | 0 |
| Nov 30, 2022 | Hariri Robert J | Chief Executive Officer | Buy | 10,000 | $1.72 | $17.2K | 0 |
| Nov 29, 2022 | Hariri Robert J | Chief Executive Officer | Buy | 40,000 | $1.71 | $68.4K | 0 |
| Nov 28, 2022 | Hariri Robert J | Chief Executive Officer | Buy | 40,000 | $1.74 | $69.6K | 0 |
CELU Insider Selling Activity
The following table shows recent insider sales of Celularity Inc. (CELU) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Apr 13, 2025 | Beers David C | Chief Financial Officer | Sell | 360 | $1.64 | $590.40 | 0 |
| Apr 13, 2025 | Brigido Stephen | Pres., Functional Regeneration | Sell | 268 | $1.64 | $439.52 | 0 |
| Apr 13, 2025 | Haines John R | Senior Exec Vice President | Sell | 577 | $1.64 | $946.28 | 0 |
| Apr 13, 2025 | Hariri Robert J | Chief Executive Officer | Sell | 1,154 | $1.64 | $1.9K | 0 |
| Feb 17, 2025 | Beers David C | Chief Financial Officer | Sell | 4,396 | $2.14 | $9.4K | 0 |
| Feb 17, 2025 | Brigido Stephen | Pres., Functional Regeneration | Sell | 3,272 | $2.14 | $7.0K | 0 |
| Feb 17, 2025 | Haines John R | Senior Exec Vice President | Sell | 7,035 | $2.14 | $15.1K | 0 |
| Jan 24, 2025 | Lim Kok Thay | 10% Owner | Sell | 1,188,255 | $2.07 | $2.46M4.9% OS | 0 |
| Apr 13, 2024 | Beers David C | Chief Financial Officer | Sell | 360 | $4.11 | $1.5K | 0 |
| Apr 13, 2024 | Brigido Stephen | Pres, Functional Regeneration | Sell | 268 | $4.11 | $1.1K | 0 |
| Apr 13, 2024 | Fletcher Kyle | See Remarks | Sell | 20 | $4.11 | $82.20 | 0 |
| Apr 13, 2024 | Haines John R | See Remarks | Sell | 576 | $4.11 | $2.4K | 0 |
| Apr 13, 2024 | Hariri Robert J | Chief Executive Officer | Sell | 1,154 | $4.11 | $4.7K | 0 |
| Mar 15, 2024 | Fletcher Kyle | See Remarks | Sell | 617 | $5.68 | $3.5K | 0 |
| Feb 16, 2024 | Beers David C | Chief Financial Officer | Sell | 43,968 | $0.43 | $19.1K | 0 |
| Feb 16, 2024 | Brigido Stephen | Pres, Functional Regeneration | Sell | 32,720 | $0.43 | $14.2K | 0 |
| Feb 16, 2024 | Fletcher Kyle | See Remarks | Sell | 39,571 | $0.43 | $17.2K | 0 |
| Feb 16, 2024 | Haines John R | See Remarks | Sell | 70,350 | $0.43 | $30.5K | 0 |
| Feb 16, 2024 | Kilcoyne Adrian | Chief Medical Officer | Sell | 52,762 | $0.43 | $22.9K | 0 |
| Apr 13, 2023 | Beers David C | Chief Financial Officer | Sell | 3,606 | $0.71 | $2.6K | 0 |
| Apr 13, 2023 | Brigido Stephen | Pres, Functional Regeneration | Sell | 2,683 | $0.71 | $1.9K | 0 |
| Apr 13, 2023 | Fletcher Kyle | See Remarks | Sell | 201 | $0.71 | $143.53 | 0 |
| Apr 13, 2023 | Glover Bradley | See Remarks | Sell | 2,884 | $0.71 | $2.1K | 0 |
| Apr 13, 2023 | Haines John R | See Remarks | Sell | 5,770 | $0.71 | $4.1K | 0 |
| Apr 13, 2023 | Hariri Robert J | Chief Executive Officer | Sell | 11,540 | $0.71 | $8.2K | 0 |
| Mar 15, 2023 | Fletcher Kyle | See Remarks | Sell | 2,170 | $0.63 | $1.4K | 0 |
| Nov 16, 2022 | Fletcher Kyle | General Counsel | Sell | 1,262 | $1.89 | $2.4K | 0 |
| Nov 16, 2021 | Glover Bradley | See Remarks | Sell | 3,734 | $1.89 | $7.1K | 0 |
| Nov 16, 2021 | Jones Anne | Chief Business Officer | Sell | 3,734 | $1.89 | $7.1K | 0 |
CELU Insiders
Similar Stocks to CELU
VRTX
Vertex Pharmaceuticals Incorporated
$438.32-2.02%
$113.59B
REGN
Regeneron Pharmaceuticals, Inc.
$600.75-2.26%
$63.34B
ALNY
Alnylam Pharmaceuticals, Inc.
$297.92-1.44%
$40.32B
RVMD
Revolution Medicines, Inc.
$164.96+4.88%
$33.48B
UTHR
United Therapeutics Corporation
$546.83-1.80%
$23.64B
INSM
Insmed Incorporated
$106.57-0.29%
$23.17B
INCY
Incyte Corporation
$95.23-1.53%
$19.33B
MRNA
Moderna, Inc.
$46.08-2.35%
$18.72B